IDH2 and central nervous system cancer: Somatic mutations in isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) have been detected in secondary glioblastomas, gliomas and acute myeloid leukemia (AML) [46–48].